[go: up one dir, main page]

SI2327792T1 - Postopki in sestavki za detektiranje avtoimunskih motenj - Google Patents

Postopki in sestavki za detektiranje avtoimunskih motenj

Info

Publication number
SI2327792T1
SI2327792T1 SI200631700T SI200631700T SI2327792T1 SI 2327792 T1 SI2327792 T1 SI 2327792T1 SI 200631700 T SI200631700 T SI 200631700T SI 200631700 T SI200631700 T SI 200631700T SI 2327792 T1 SI2327792 T1 SI 2327792T1
Authority
SI
Slovenia
Prior art keywords
compositions
methods
immune disorders
detecting auto
detecting
Prior art date
Application number
SI200631700T
Other languages
English (en)
Inventor
Alexander Abbas
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of SI2327792T1 publication Critical patent/SI2327792T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200631700T 2005-08-05 2006-08-02 Postopki in sestavki za detektiranje avtoimunskih motenj SI2327792T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70620505P 2005-08-05 2005-08-05
EP10188070.6A EP2327792B9 (en) 2005-08-05 2006-08-02 Methods and compositions for detecting auto-immune disorders

Publications (1)

Publication Number Publication Date
SI2327792T1 true SI2327792T1 (sl) 2013-12-31

Family

ID=37663302

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631700T SI2327792T1 (sl) 2005-08-05 2006-08-02 Postopki in sestavki za detektiranje avtoimunskih motenj

Country Status (12)

Country Link
US (3) US20070092890A1 (sl)
EP (2) EP1945800B1 (sl)
AT (1) ATE549416T1 (sl)
AU (1) AU2006278561C1 (sl)
CA (1) CA2614455A1 (sl)
DK (1) DK2327792T3 (sl)
ES (2) ES2432026T3 (sl)
HK (1) HK1158700A1 (sl)
PL (1) PL2327792T3 (sl)
PT (1) PT2327792E (sl)
SI (1) SI2327792T1 (sl)
WO (1) WO2007019219A2 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2557180B1 (en) * 2006-04-24 2014-07-09 Genentech, Inc. Methods for dectecting autoimmune disorders
US20100143373A1 (en) * 2006-12-06 2010-06-10 Medimmune, Llc Methods of treating systemic lupus erythematosus
US20100261172A1 (en) * 2007-05-03 2010-10-14 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
AU2008247398B2 (en) * 2007-05-03 2013-10-10 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
CN104593488B (zh) 2007-05-21 2018-06-12 健泰科生物技术公司 用于鉴定和治疗狼疮的方法和组合物
KR20100098620A (ko) * 2007-11-05 2010-09-08 메디뮨 엘엘씨 경피증의 치료 방법
AU2009212216B2 (en) * 2008-02-08 2015-04-09 Brigham And Women's Hospital, Inc. Disease markers and uses thereof
RU2012112802A (ru) * 2009-09-03 2013-10-10 МЕДИММЬЮН, ЭлЭлСи Диагностика интерферона типа 1
CN102687007B (zh) * 2009-09-18 2015-07-22 罗格斯州立大学 利用分层标准化切割的高处理量生物标志物分割
CN113025703A (zh) 2009-10-07 2021-06-25 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
US8824769B2 (en) * 2009-10-16 2014-09-02 General Electric Company Process and system for analyzing the expression of biomarkers in a cell
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
ES2372762B1 (es) * 2010-07-02 2012-11-28 Consejo Superior De Investigaciones Científicas (Csic) Método y kit para la detección de la activación de interferón y la respuesta inflamatoria independiente de interferón.
US20130216557A1 (en) * 2010-08-14 2013-08-22 Biogen Idec Ma Inc. Ltbr blockade: methods for optimizing therapeutic responsiveness of patients
WO2016179268A1 (en) * 2015-05-05 2016-11-10 University Of Florida Research Foundation, Inc. Diagnostic microarray, system and method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1999052539A1 (en) * 1998-04-10 1999-10-21 Mayo Foundation For Medical Education And Research Neo-tryptophan
EP1276702A2 (en) 2000-03-31 2003-01-22 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
US20030148298A1 (en) * 2001-04-03 2003-08-07 O''toole Margot Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
AU2003299503A1 (en) * 2002-05-16 2004-06-15 Vanderbilt University Method for predicting autoimmune diseases
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
EP2179742A1 (en) * 2002-11-26 2010-04-28 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
US20060018875A1 (en) * 2004-06-14 2006-01-26 Blatt Lawrence M Interferon compositions and methods of use thereof
EP1789798A4 (en) * 2004-08-13 2009-02-18 Xceed Molecular Corp MARKER FOR DETECTION OF AUTOIMMUNE DISEASES
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus

Also Published As

Publication number Publication date
EP2327792A1 (en) 2011-06-01
WO2007019219A3 (en) 2007-05-31
PL2327792T3 (pl) 2014-03-31
US20100279298A1 (en) 2010-11-04
ES2383966T3 (es) 2012-06-27
EP2327792B1 (en) 2013-10-02
ATE549416T1 (de) 2012-03-15
US20070092890A1 (en) 2007-04-26
PT2327792E (pt) 2013-11-21
US20080318800A1 (en) 2008-12-25
AU2006278561C1 (en) 2013-05-02
CA2614455A1 (en) 2007-02-15
WO2007019219A2 (en) 2007-02-15
ES2432026T3 (es) 2013-11-29
AU2006278561B2 (en) 2012-11-01
DK2327792T3 (da) 2014-01-13
HK1158700A1 (en) 2012-07-20
EP1945800B1 (en) 2012-03-14
AU2006278561A1 (en) 2007-02-15
EP1945800A2 (en) 2008-07-23
EP2327792B9 (en) 2013-12-18

Similar Documents

Publication Publication Date Title
SI2327792T1 (sl) Postopki in sestavki za detektiranje avtoimunskih motenj
PH12013501101A1 (en) Immunosuppressive polypeptides and nucleic acids
AP2280A (en) Compositions and methods for increasing telomeraseactivity.
TW200732349A (en) Anti-OX40L antibodies and methods using same
HK1099027A1 (en) Monovalent antibody fragments useful as therapeutics
WO2006104912A3 (en) C-met mutations in lung cancer
WO2007002204A3 (en) Pyrosequencing methods and related compostions
EP1894359A4 (en) METHOD AND ARRANGEMENT FOR THE DETERMINATION OF ROAD COSTS AND SELECTION WITH INTERACTION OF ROAD COSTS
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
TW200727920A (en) New regimens for oral monophasic contraceptives
EP1918370A4 (en) ANTIGEN PCNA MUTANT
IL184834A0 (en) Compositions and methods for the manufacture thereof
BRPI0417992B8 (pt) métodos para purificar fsh humano recombinante ou uma variante de fsh
EP1770399A4 (en) INSPECTION INSTRUMENT
PL1934955T3 (pl) Podświetlany żeton
WO2006098998A3 (en) Methods and compositions for modulating vascular integrity
GB0502396D0 (en) Tapping the vacume 1
GB0521873D0 (en) Pure 03 serums
WO2005118859A3 (en) Carrier tests for albinism in the cat
IL189803A0 (en) Device for determining the relative position between two essentially flat elements
WO2006064517A3 (en) Methods for the purification of 20(s)-camptothecin
IL185408A0 (en) (+)-and(-)-8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1)oct-2-ene
WO2005118881A3 (en) Carrier tests for polycystic kidney disease in the cat
PL375122A1 (pl) Statyw szynowy
AU306807S (en) Hand rail bracket